Burjeel Cancer Institute launches new facility for breast health
The Burjeel Breast Center is poised to become a one-stop destination for women with both malignant and benign breast conditions, providing a spectrum of services from screening to treatment.
Situated within Burjeel Medical City, it is designed to offer same-day appointments and diagnoses during the initial consultation.
It has a women-led medical team and a special unit dedicated to breast reconstruction for surgical cases.
Technology is a cornerstone of the facility, with the HOLOGIC 3Dimensions Mammography System leading the charge for early and precise detection of breast abnormalities.
The integration of AI-driven breast radiology systems further enhances the diagnostic process by aiding radiologists in interpreting ultrasounds, mammograms and MRIs, thereby minimising the likelihood of incorrect diagnoses.
Burjeel Cancer Institute CEO Humaid Al Shamsi said: 'The Burjeel Breast Center reimagines the breast care journey by offering an empathetic, data-driven, and efficient clinical environment.
'By removing barriers to early detection such as long wait times and the need for prior appointments, we are empowering women to take charge of their health. Early intervention is key, and our walk-in model ensures no time is lost.'
Another aspect of the facility is the introduction of the Survivorship Lounge, an initiative aimed at supporting breast cancer survivors. The space focuses on life post-treatment, offering resources and support to empower survivors.
Burjeel Holdings Group CEO John Sunil said: 'The launch of Burjeel Breast Center reflects our commitment to raising the standard of women's healthcare in the region.'
In addition to the centre, Burjeel Cancer Institute is set to launch the Burjeel Cancer Institute Pharmacy.
In February 2025, Burjeel Holdings acquired an 80% stake in Advanced Care Oncology Center, with plans to establish a radiation oncology network across the Gulf Cooperation Council region.
"Burjeel Cancer Institute launches new facility for breast health" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
20 hours ago
- Boston Globe
Sarepta tells FDA it won't halt shipments despite patient deaths
Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'We believe in access to drugs for unmet medical needs but are not afraid to take immediate action when a serious safety signal emerges,' FDA Commissioner Marty Makary said in a statement. Advertisement Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects males, though it has faced scrutiny since its clearance in 2023. The one-time treatment received accelerated approval against the recommendations of some FDA scientists who doubted its effectiveness. Bloomberg The FDA granted full approval last year and expanded the therapy's use to patients 4 years and older, including those who can no longer walk. Previously, it was only available for younger patients who were still walking. Advertisement Sarepta said Friday that its scientific review showed 'no new or changed safety signals' for younger patients with Duchenne's who have earlier stages of the disease. The company said it plans to keep the drug available for those patients. 'We look forward to continued discussions and sharing of information with FDA,' the company said in a statement. Sarepta halted shipments last month of the therapy for older boys with Duchenne's, which gradually destroys muscle and skeletal strength, resulting in early death. The move followed the deaths of two teenage boys taking the therapy. The company also confirmed a third death Friday: a 51-year-old patient who was taking an experimental gene therapy in a trial for a different form of muscular dystrophy. Sarepta said it reported the death to the FDA on June 20. The FDA said Friday it placed that trial on hold. Sarepta noted that the gene therapy involved in the incident uses 'a different dose and is manufactured using a different process,' than Elevidys. All three patient deaths were linked to liver injury, a side effect noted in Sarepta's prescribing information. Earlier this week Sarepta announced it would add a bold warning to drug and lay off a third of its employees. The company did not mention the third patient death in its news release or conference call announcing those changes, sparking pointed criticism from Wall Street analysts. Company shares fell more than 35% Friday to close at $14.07. Cambridge, Massachusetts-based Sarepta has received FDA approval for three other Duchenne's drugs since 2016, none of which have been confirmed to work. The company has long been criticized for failing to complete several studies needed to secure full FDA approval of its drugs. Advertisement
Yahoo
21 hours ago
- Yahoo
‘Inhumane conditions' at Idaho maximum security prison prompt planned hunger strike
Dozens of men incarcerated at the Idaho Maximum Security Institution have been refusing to eat to protest 'inhumane conditions' at the prison, according to a news release from Return Strong, a Nevada-based advocacy organization for incarcerated people. The Idaho Department of Correction confirmed that nearly 90 men refused to take their breakfast Friday morning as part of 'what appears to be a peaceful, planned demonstration,' spokesperson Sanda Kuzeta-Cerimagic told the Idaho Statesman. She said the prisoners have been asking for visitation rights and better programming at the institution. Friday's protest marks the second time men incarcerated at the Idaho Maximum Security Institution organized a mass hunger strike to demand better treatment and services within the last year and a half, though IDOC leadership in the past has taken issue with use of the term. According to the agency's policy definitions, the demonstration is only a considered a 'hunger strike' when the men have refused to eat or drink for at least three days. In May 2024, roughly 90 men primarily housed at the maximum prison refused their meals for six days. Several of them told the Statesman they were protesting the substandard living conditions, including long bouts of isolation and 'cages' IDOC used for recreation time, covered in human feces. Prisoners also brought up concerns over access to certain religious practices, rehabilitative programming and a lack of visitation options. Return Strong Executive Director Jodi Hocking on Friday again pointed to 'systemic medical neglect and indefinite isolation without rehabilitation' in its news release, and said the organization is urging the state prison system's leadership to take 'immediate steps to address these dangerous and degrading conditions.' Return Strong said the prison offered months of delay for one individual with a broken wrist and finger, limited mental health care, mold covering the shower walls, restricted visitation, took away access to fruit and stuck prisoners with years of solitary confinement. 'When incarcerated people feel they have no voice and no path to dignity, they turn to peaceful protest,' Hocking said in the news release. 'These men are standing up not just for themselves, but for the humanity of all people in prison.' Kuzeta-Cerimagic said that about six months ago, the prison implemented a reward system for people in close custody, a high-security custody level often used for maximum security prisoners. Individuals who meet certain criteria, like being at least six months free of disciplinary offense reports and agreeing to live in a mixed unit not separated by gang affiliation, receive double dayroom time, one physical visit a week and additional opportunities for programming and jobs, she said. Fruit remains restricted because it's used in homemade alcohol, and it has been substituted with fresh vegetables, Kuzeta-Cerimagic said. She denied allegations of black or green mold, adding that some showers within the prison are expected to be repaired or refinished. 'We hope to resolve the situation without escalation,' Kuzeta-Cerimagic said. Dewey Lewis, who's 53 and has been incarcerated since the '90s, said many of the concerns he and others raised from Idaho's maximum security prison last year still exist. He reiterated allegations that recreational areas were littered with human urine and feces, since they don't have access to a bathroom for hours. It's the second time he's recently participated in a planned hunger strike at the prison. He said he's taking part in the protest again with the hope of raising awareness of the prison's conditions and to push for change.
Time Business News
a day ago
- Time Business News
GMP Certification Services for Tenders in Qatar
In Qatar's tightly regulated pharmaceutical, food, and healthcare industries, obtaining GMP (Good Manufacturing Practice) certification has become a strategic necessity—especially for businesses looking to secure government contracts. Whether supplying medicines to Hamad Medical Corporation, manufacturing packaged foods for schools, or producing cosmetics for hospital use, GMP compliance proves your company's dedication to safety, quality, and international best practices. Government institutions in Qatar—including those under the Ministry of Public Health (MoPH)—require that suppliers meet international safety and quality standards. GMP certification ensures that your production environment: Maintains hygienic facilities Follows documented procedures Ensures employee competence and training Tracks product batches for recall readiness Implements continuous quality control systems This reduces risk for public agencies and aligns with the Qatar National Vision 2030 commitment to high health and safety standards. GMP supports Qatar's broader goals for consumer protection, public health, and economic diversification. Companies that implement GMP are better equipped to meet regulations enforced by MoPH and international partners. This is especially critical in sectors supplying: Public healthcare and hospitals Government-run food programs Military and municipal supply chains By aligning with GMP standards, your business becomes a preferred vendor in Qatar's growing public sector. Pharmaceuticals – To qualify for MoPH registration and government tenders – To qualify for MoPH registration and government tenders Food and Beverage Manufacturing – Especially for institutional or export markets – Especially for institutional or export markets Cosmetics & Personal Care – For supplies to hotels, hospitals, and wellness centers – For supplies to hotels, hospitals, and wellness centers Medical Devices & Supplements – Subject to increased scrutiny under health regulations Improves Evaluation Scores – Many RFQs assign points to quality compliance and safety systems. Demonstrates Operational Maturity – GMP shows your business has predictable, traceable processes. Accelerates Government Approvals – Certified businesses face fewer technical clarifications. Builds Procurement Trust – Officials prefer working with vendors that proactively manage risk. To become GMP certified, companies typically follow these five stages: Gap Analysis – Evaluate compliance with GMP standards System Development – Create or update SOPs, sanitation procedures, and documentation Employee Training – Educate teams on hygiene, safety, and process control Internal Audit – Conduct a mock audit to identify areas of improvement Third-Party Certification – Undergo assessment by an accredited GMP certification body Working with a Qatar-based GMP consultancy ensures that documentation and practices meet local and international requirements, accelerating approval. Government procurement in Qatar emphasizes reliability, hygiene, and international standardization. GMP-certified companies are: Seen as low-risk, high-trust suppliers More likely to meet regulatory benchmarks Positioned to win tenders in healthcare, food, and industrial supply chains Aligned with sustainability and transparency goals of Vision 2030 In Qatar's public procurement system, GMP is no longer optional—it's a key to eligibility and long-term success. From compliance to competitiveness, GMP gives your company the edge it needs to secure government tenders and operate at global standards. Whether you're a food processor, pharmaceutical company, or cosmetic product manufacturer, GMP certification positions your business as a trusted partner for national development goals. If you're preparing to pursue tenders, we recommend exploring reliable GMP certification services in Qatar that offer local expertise, regulatory alignment, and full support from documentation to audit. Partnering with an experienced team can significantly streamline your certification journey and boost your tender success rate. TIME BUSINESS NEWS
